Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 2/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.33 |
| ▸ | F9 | P00740 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27012131 | 0.90 | ALOX5 (0.41) | ALOX5PTPN1HSD17B1HSD17B2LIMK1 | |
| SCHEMBL19077284 | 0.87 | NQO1 (0.33) | ALOX5PTPN1LIMK1NQO1NQO2 | |
| SCHEMBL19103061 | 0.86 | PTPN1 (0.37) | ALOX5PTPN1HSD17B1HSD17B2LIMK1 | |
| SCHEMBL17931894 | 0.86 | PTPN1 (0.40) | ALOX5PTPN1NQO1NQO2TNKS | |
| SCHEMBL18267023 | 0.84 | ALOX5 (0.39) | ALOX5PTPN1LIMK1NQO1NQO2 | |
| SCHEMBL22706277 | 0.84 | ALOX5 (0.41) | ALOX5PTPN1LIMK1NQO1NQO2 | |
| SCHEMBL22708226 | 0.84 | ALOX5 (0.40) | ALOX5PTPN1LIMK1NQO1NQO2 | |
| SCHEMBL24877070 | 0.83 | LIMK1 (0.35) | ALOX5PTPN1HSD17B1HSD17B2LIMK1 | |
| SCHEMBL19197073 | 0.83 | MEN1 (0.42) | ALOX5PTPN1LIMK1NQO1NQO2 | |
| SCHEMBL17383118 | 0.82 | ALOX5 (0.39) | ALOX5PTPN1HSD17B1HSD17B2LIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674117-B2 | Organoboron compound and method for manufacturing the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8674117-B2 | Organoboron compound and method for manufacturing the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8674117-B2 | Organoboron compound and method for manufacturing the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-03-18 | — | — | US | disclosed |
| US-20120165550-A1 | Organoboron Compound and Method for Manufacturing the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-06-28 | — | — | US | disclosed |
| US-20120165550-A1 | Organoboron Compound and Method for Manufacturing the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-06-28 | — | — | US | disclosed |
| US-20120165550-A1 | Organoboron Compound and Method for Manufacturing the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165550-A1 | Organoboron Compound and Method for Manufacturing the Same | CYP2B6, CBR3, CBR1 | ALOX5 3059/4885PTPN1 3483/4885HSD17B1 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.